Clinical Trial Update: Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating genomics and epigenomics of the elderly response to pneumococcal vaccines; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: The Jackson Laboratory | Conditions: Pneumonia, Aging | Phase 4 | Status: COMPLETED | Results posted: 2021-12-07